These changes reflect enhancement of both the initiation and amplification phases of coagulation, likely driven by tumor-associated procoagulant factors, such as tissue factor expression and subsequent activation of factor VII [31] and inflammatory cytokines [32], in dogs with cardiac tumors [33]. The gene discussed is F3; the disease is heart neoplasm.